NBRV - Nabriva Therapeutics Plc (NBRV) CEO Ted Schroeder on Q1 2020 Results - Earnings Call Transcript
Nabriva Therapeutics Plc (NBRV)
Q1 2020 Earnings Conference Call
May 11, 2020 16:30 ET
Company Participants
Gary Sender - Chief Financial Officer
Ted Schroeder - Chief Executive Officer
Jennifer Schranz - Chief Medical Officer
Francesco Maria Lavino - Chief Commercial Officer
Steve Gelone - President & Chief Operating Officer
Conference Call Participants
Alan Carr - Needham & Company
Kevin Kedra - G.Research
Presentation
Operator
Ladies and gentlemen, thank you for standing by and welcome to the Nebraska Therapeutics First Quarter 2020 Financial Results Conference Call. At this time all participants' lines are in a listen-only